Qianfei Wang, PhD¹, Jingfang Dong, PhD^1*, Ryan Mattison, MD^1*, Shyam Prabhakar, PhD^2*, Fabio Eiji Arimura^3*, Joseph Kaberlein^1*, Chong-zhi Wang, PhD^4*, Qianben Wang, PhD^5*, Marcelo Nobrega, PhD^3* and Michael Thirman, MD¹

¹Medicine, University of Chicago, Chicago, IL
²Genome Institute of Singapore, Genome, Singapore
³Human Genetics, University of Chicago, Chicago, IL
⁴Anesthesia & Critical Care, University of Chicago, Chicago, IL
⁵Dana-Farber Cancer Institute and Harvard Medical School, Boston

Ashish Kumar, MBBS, PhD¹, Baolin Wu^2* and John H. Kersey, MD³

¹Pediatric Heme/Onc/BMT, University of Minnesota, Minneapolis, MN
²Biostatistics Division, School of Public Health, University of Minnesota, Minneapolis, MN
³Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN

R. Katherine Hyde, PhD^1*, Yasuhiko Kamikubo, MD, PhD^1*, Lemlem Alemu^1*, Ling Zhao, MD, PhD^1*, Chenwei Wang^2* and Pu Paul Liu, MD, PhD¹

¹Gmbb/Ods, NIH/NHGRI, Bethesda, MD
²Gtb, NHGRI/NIH, Bethesda, MD

Sophie Kusy^1*, Nicolas Goardon, PhD^2*, Florence Armstrong^3*, Francoise Pflumio^3* and paul-Henri Romeo^1*

¹Laboratoire de recherche sur la Réparation et la Transcription dans les cellules Souches (LRTS), Institut de Radiobiologie Cellulaire et Moléculaire (IRCM), CEA, Fontenay-aux-Roses cedex, France
²Weatherall Institute of Molecular Medicine, University of Oxford, MRC Molecular Haematology Unit, Oxford, United Kingdom
³Laboratoire de recherche sur les cellules Souches Hématopoïétiques et Leucémiques (LSHL), Institut de Radiobiologie Cellulaire et Moléculaire (IRCM), CEA, Fontenay-aux-Roses cedex, France

Lin Yang^1* and Robert Z. Orlowski, MD, PhD²

¹Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
²University of Texas M. D. Anderson Cancer Center, Houston, TX

Valérie Capraro^1*, Linda Zane^1*, Lauriane Kuhn^2*, Jérôme Garin^3*, Perrine Galia^4*, Claude Preudhomme^5*, Eric Gilson^6*, Xavier Thomas⁷, Mohamed Elhamri^8*, Youcef Chelgoun^8*, Nathalie Bonnefoy-Berard^9*, Franck Mortreux^1* and Eric Wattel^1*

¹Oncovirologie et Biotherapies, CENTRE LEON BERARD, FRE CNRS 3011, Université Lyon 1, LYON Cedex 08, France
²Laboratoire d'Etude de la Dynamique des Protéomes, CEA / Inserm 0880 / UJF, Grenoble CEDEX 09, France
³Laboratoire d'Etude de la Dynamique des Protéomes, CEA / Inserm 0880 / UJF, Grenoble Cedex 09, France
⁴Oncovirologie ET Biotherapies, CENTRE LEON BERARD, FRE CNRS 3011, Université Lyon 1, LYON Cedex 08, France
⁵MILE Study Group, on Behalf of European LeukemiaNet (ELN, WP13), Munich, Germany
⁶Lbmc, Cnrs UMR5239, Ifr 128, FACULTE DE MEDECINE DE LYON SUD, UNIVERSITE LYON 1, Villeurbanne
⁷GRAALL Group, Lyon, France
⁸Hematology Department, Hospices Civils de Lyon, Lyon, France
⁹IFR Biosciences Lyon-Gerland, Laboratoire d'homéostasie lymphocytaire, INSERM U503, Lyon, France

Alexander Kohlmann, PhD¹, Lars Bullinger, MD², Christian Thiede, MD^3*, Markus Schaich, MD³, Susanne Schnittger, PhD¹, Konstanze Dohner, MD^2*, Martin Dugas, MD^4*, Hartmut Dohner, MD^2*, Gerhard Ehninger, MD³ and Torsten Haferlach, MD¹

¹MLL Munich Leukemia Laboratory, Munich, Germany
²Internal Medicine III, University of Ulm, Ulm, Germany
³Medical Clinic I, University Hospital, Dresden, Germany
⁴Department of Medical Informatics and Biomathematics, University of Münster, Münster, Germany

Hao Wang, MD^1*, Stephan Lindsey, PhD^1*, Iwona Konieczna^1*, Elizabeth Horvath, MS^2*, Ling Bei, MD³, Weiqi Huang, MD, PhD^3* and Elizabeth A. Eklund, MD²

¹Medicine, Northwestern University, Chicag, IL
²Northwestern University Feinberg School of Medicine and Jesse Brown VA Medical Center, Chicago, IL
³Hematology/Oncology, Robert H. Lurie Comp. Cancer Ctr., Chicago, IL